Atypical Endometrial Hyperplasia Arising in a Cesarean Section Scar: A Mechanism of Malignant Transformation.

Atypical endometrial hyperplasia Cesarean section Endometriosis Obesity

Journal

Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601

Informations de publication

Date de publication:
Historique:
received: 14 03 2019
accepted: 19 03 2019
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 28 5 2019
Statut: epublish

Résumé

The incidence of scar endometriosis in Cesarean sections varies between 0.03 and 0.4%. However, the recently increased rate of Cesarean sections worldwide may be causing an increase in occurrence of scar endometriosis. This report presents anatomopathological evidence of an early-stage malignant transformation in endometriotic tissue from a post-Cesarean scar and briefly reviews possible underlying mechanisms. A 40-year-old woman with a body mass index of 42.7 was referred to the gynecological department with recurrent pain and presence of a palpable mass in her Cesarean section scar. She had undergone this procedure 7 years earlier and began experiencing discomfort and pain at the incision site 6 months postoperatively. Surgical treatment was instituted with complete removal of the lesion. Anatomopathological examination revealed endometriotic tissue intertwined with atypical endometrial hyperplasia and fibrosis. At 2 years' follow-up, she was asymptomatic, both clinically and based on ultrasound examination. Endometriotic foci inoculated within an abdominal scar may undergo malignant transformation. Long-lasting abdominal scar endometriosis, in morbidly obese women, requires special attention from the physician.

Identifiants

pubmed: 31123458
doi: 10.1159/000499760
pii: cro-0012-0317
pmc: PMC6514506
doi:

Types de publication

Case Reports

Langues

eng

Pagination

317-321

Références

Obstet Gynecol. 2002 Oct;100(4):788-95
pubmed: 12383550
Obstet Gynecol. 1953 Sep;2(3):283-9
pubmed: 13087921
Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):349-71
pubmed: 15157647
Int J Gynaecol Obstet. 2005 Sep;90(3):218-22
pubmed: 16040035
Taiwan J Obstet Gynecol. 2008 Mar;47(1):42-8
pubmed: 18400581
BMC Cancer. 2009 Sep 16;9:330
pubmed: 19758455
Am J Obstet Gynecol. 2011 Jan;204(1):63.e1-7
pubmed: 21074136
Semin Reprod Med. 2012 Jan;30(1):39-45
pubmed: 22271293
Int J Mol Sci. 2013 Mar 06;14(3):5367-79
pubmed: 23466883
J Clin Epidemiol. 2014 Jan;67(1):46-51
pubmed: 24035173
Fertil Steril. 2014 Aug;102(2):342-4
pubmed: 24880652
Int J Gynecol Cancer. 2015 Mar;25(3):447-52
pubmed: 25695548
Int J Gynecol Cancer. 2015 Nov;25(9):1633-8
pubmed: 26448542
Medicine (Baltimore). 2017 Dec;96(49):e9136
pubmed: 29245355
Cancer. 1985 Jul 15;56(2):403-12
pubmed: 4005805

Auteurs

Marta Monist (M)

2nd Department of Gynecology, Lublin Medical University, Lublin, Poland.

Dorota Lewkowicz (D)

Department of Clinical Pathology, Lublin Medical University, Lublin, Poland.

Maciej Jóźwik (M)

Department of Gynecology and Gynecologic Oncology, Białystok Medical University, Białystok, Poland.

Marek Gogacz (M)

2nd Department of Gynecology, Lublin Medical University, Lublin, Poland.

Michał Bogusiewicz (M)

2nd Department of Gynecology, Lublin Medical University, Lublin, Poland.

Tomasz Rechberger (T)

2nd Department of Gynecology, Lublin Medical University, Lublin, Poland.

Andrzej Semczuk (A)

2nd Department of Gynecology, Lublin Medical University, Lublin, Poland.

Classifications MeSH